THPO, thrombopoietin, 7066

N. diseases: 185; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.020 Biomarker disease BEFREE <b>Expert opinion</b>: The most commonly used treatments after failure of upfront immunosuppression are hematopoietic stem cell transplantation, a second course of immunosuppression and thrombopoietin mimetics alone or in combination with immunosuppression. 31311355 2019
CUI: C4048329
Disease: Immunosuppression
Immunosuppression
0.020 GeneticVariation disease BEFREE Recognizing patients with <i>THPO</i> mutations among those with juvenile bone marrow failure is essential to provide them with appropriate substitutive therapy and prevent the use of invasive and unnecessary treatments, such as hematopoietic stem cell transplantation or immunosuppression. 29191945 2018